Pyxis Oncology Ratios (2020-2025) | PYXS

Ratios Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin (Quarter)
97.06%100.00%78.37%
EBT Margin (Quarter)
-33.09%-640.82%-154.04%
EBIT Margin (Quarter)
-34.71%-700.35%-165.75%
EBITDA Margin (Quarter)
-20.93%-652.77%-164.18%
Operating Margin (Quarter)
-34.71%-700.35%-165.75%
Net Margin (Quarter)
-33.09%-640.82%-164.16%
FCF Margin (Quarter)
-129.73%-612.16%-94.46%
Efficiency
Assets Average (Quarter)
209.75M266.36M247.63M233.23M217.64M197.09M179.02M180.96M180.21M196.97M214.30M201.85M176.25M146.52M129.54M114.41M98.56M
Equity Average (Quarter)
-32.83M-53.80M-64.51M94.94M247.41M222.74M200.36M174.79M156.49M148.72M141.61M131.82M154.93M176.97M161.74M137.22M111.93M95.37M78.21M61.09M
Invested Capital (Quarter)
-50.02M-57.59M-62.32M261.31M233.51M211.97M188.75M160.82M152.16M145.28M137.95M125.70M184.16M169.79M153.68M120.75M103.10M87.64M68.78M53.41M
Asset Utilization Ratio (Quarter)
0.090.020.020.14
Leverage & Solvency
Debt to Equity (Quarter)
-0.13
Debt Ratio (Quarter)
0.07
Equity Ratio (Quarter)
-0.510.930.920.870.840.760.830.830.740.720.840.810.790.770.760.710.650.58
Valuation
Enterprise Value (Quarter)
-140.66M-142.47M-133.48M-276.21M-248.56M-224.83M-200.01M-180.76M-54.53M-27.37M-132.97M-119.30M-157.03M-26.55M-13.53M-20.95M-105.43M-88.94M-10.39M-16.89M
Return Ratios
Return on Sales (Quarter)
0.00%-0.05%-0.06%-0.35%-0.02%
Return on Capital Employed (Quarter)
-36.49%-26.45%-36.59%-47.60%-66.39%-60.94%-62.10%-67.09%-53.22%-36.56%-34.83%-37.00%-56.42%-80.83%-95.19%-111.75%-109.03%
Return on Invested Capital (Quarter)
-0.01%-0.01%-0.01%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%
Return on Equity (Quarter)
0.01%0.01%-0.01%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%